Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
ADIAL PHARMACEUTICALS, INC. (ADIL)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | | -4409.8% | -1133.2% | | | | |
ROIC (including intangibles) | 1709.1% | 5604.3% | -1173.8% | -912.5% | 127.5% | 219.6% | -9218.8% |
ROE | -490.4% | -274.2% | -115.5% | -157.3% | 99.8% | 394.1% | -502.2% |
ROA | -230.1% | -199.0% | -107.4% | -148.7% | -2881.0% | -271.1% | -378.9% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | | | 0.0 | 0.0 | | |
Days payables outstanding | | | | -4.3 | | | |
Cash conversion cycle | | | | 4.3 | 0.0 | | |
|